Abstract
Pseudomonas aeruginosa (PA) is a ubiquitous environmental Gram-negative bacterium found in soil and water. This opportunistic pathogen can cause infections in individuals with impaired phagocytic function, such as those with burns, exposure to chemotherapy, or cystic fibrosis (CF). PA infects the lungs of most individuals with CF, and is associated with severe progressive pulmonary disease that is the major cause of premature death in this disorder. The specific adaptations of PA to the CF airway responsible for bacterial persistence and antibiotic tolerance are not completely understood but may include increased alginate production (i.e., mucoid phenotype), biofilm formation, and specific lipid A modifications. During adaptation to the CF airway, PA synthesizes a variety of lipid A structures that alter host innate immune responses and promote bacterial persistence and chronic infection. The synthesis of specific lipid A structures is attributable to bacterial enzymes that: (1) remove the 3OH-C10:0 acyl chain from the 3-position (PagL); (2) add a C16:0 acyl chain to the 3OH-C10:0 chain at the 3’-position (PagP); (3) add C12:0 and 2OH-C12:0 acyl chains to the 3OH-C12:0 chains at the 2- and 2’-positions (HtrB and LpxO); and (4) add aminoarabinose to phosphate groups at the 1- and 4’-positions (PmrH, PmrF, PmrI, PmrJ, PmrK, and PmrE). These lipid A modifications represent an essential aspect of PA adaptation to the CF airway.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- PA:
-
Pseudomonas aeruginosa
- CF:
-
cystic fibrosis
- LPS:
-
lipopolysaccharide
References
Ballard, S.T., Trout, L., Bebok, Z., Sorscher, E.J., Crews, A. CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands. Am J Physiol 277 (1999) L694–699.
Bhat, R., Marx, A., Galanos, C., Conrad, R.S. Structural studies of lipid A from Pseudomonas aeruginosa PAO1: occurrence of 4-amino-4-deoxyarabinose. J Bacteriol 172 (1990) 6631–6636.
Bonfield, T.L., Konstan, M.W., Burfeind, P., Panuska, J.R., Hilliard, J.B. Berger, M., Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is down-regulated in cystic fibrosis. Am J Respir Cell Mol Biol 13 (1995) 257–261.
Boucher, J.C., Yu, H., Mudd, M.H., Deretic, V. Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65 (1997) 3838–3846.
Burns, J.L., Gibson, R.L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A.L., Ramsey, B.W. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183 (2001) 444–452.
Burns, J.L., Van Dalfsen, J.M., Shawar, R.M., Otto, K.L., Garber, R.L., Quan, J.M., Montgomery, A.B., Albers, G.M., Ramsey, B.W., Smith, A.L. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis 179 (1999) 1190–1196.
Cystic Fibrosis Foundation. CFF Patient Registry. Patient Registry Annual Data Report 2007. Bethesda, Maryland (2009).
Davis, P.B., Drumm, M., Konstan, M.W. Cystic fibrosis. Am J Respir Crit Care Med 154 (1996) 1229–1256.
Ernst, R.K., Hajjar, A.M., Tsai, J.H., Moskowitz, S.M., Wilson, C.B., Miller, S.I. Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. J Endotoxin Res 9 (2003) 395–400.
Ernst, R.K., Yi, E.C., Guo, L., Lim, K.B., Burns, J.L., Hackett, M., Miller, S.I. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286 (1999) 1561–1565.
Geurtsen, J., Steeghs, L., Hove, J.T., van der Ley, P., Tommassen, J. Dissemination of lipid A deacylases (pagL) among gram-negative bacteria: identification of active-site histidine and serine residues. J Biol Chem 280 (2005) 8248–8259.
Gibbons, H.S., Lin, S., Cotter, R.J., Raetz, C.R. Oxygen requirement for the biosynthesis of the S-2-hydroxymyristate moiety in Salmonella typhimurium lipid A. Function of LpxO, A new Fe2+/alpha-ketoglutarate-dependent dioxygenase homologue. J Biol Chem 275 (2000) 32940–32949.
Goldman, R.C., Doran, C.C., Kadam, S.K., Capobianco, J.O. Lipid A precursor from Pseudomonas aeruginosa is completely acylated prior to addition of 3-deoxy-D-manno-octulosonate. J Biol Chem 263 (1988) 5217–5223.
Goto, T., Nakame, Y., Nishida, M., Ohi, Y., Bacterial biofilms and catheters in experimental urinary tract infection. Int J Antimicrob Agents 11 (1999) 227–231.
Hajjar, A.M., Ernst, R.K., Tsai, J.H., Wilson, C.B., Miller, S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 3 (2002) 354–359.
Hancock, R.E.W., Mutharia, L.M., Chan, L., Darveau, R.P., Speert, D.P., Pier, G.B. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum sensitive, nontypable strains deficient in lipopolysaccharide side chains. Infect Immun 42 (1983) 170–177.
Henry, R.L., Mellis, C.M., Petrovic, L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 12 (1992) 158–161.
Jayaraman, S., Joo, N.S., Reitz, B., Wine, J.J. Verkman, A.S. Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc Natl Acad Sci USA 98 (2001) 8119–8123.
Karunaratne, D.N., Richards, J.C., Hancock, R.E.W. Characterization of lipid A from Pseudomonas aeruginosa O-antigenic B band lipopolysaccharide by 1D and 2D NMR and mass spectral analysis. Arch Biochem Biophys 299 (1992) 368–376.
Knowles, M.R., Boucher, R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109 (2002) 571–577.
Kulshin, V.A., Zahringer, U., Lindner, B., Jager, K.E., Dmitriev, B.A., Rietschel, E.T. Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides. Eur J Biochem 198 (1991) 697–704.
Li, Z., Kosorok, M.R., Farrell, P.M., Laxova, A., West, S.E., Green, C.G., Collins, J., Rock, M.J., Splaingard, M.L. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. Jama 293 (2005) 581–588.
Lyczak, J.B., Cannon, C.L., Pier, G.B. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2 (2000) 1051–1060.
Macfarlane, E.L., Kwasnicka, A., Hancock, R.E. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146(Pt 10) (2000) 2543–2554.
Macfarlane, E.L., Kwasnicka, A., Ochs, M.M., Hancock, R.E. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol Microbiol 34 (1999) 305–316.
Mahenthiralingam, E., Campbell, M.E., Speert, D.P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62 (1994) 596–605.
McPhee, J.B., Lewenza, S., Hancock, R.E. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50 (2003) 205–217.
Miller, S.I., Ernst, R.K., Bader, M.W. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3 (2005) 36–46.
Moskowitz, S.M., Burns, J.L., Nguyen, C.D., Høiby, N., Ernst, R.K., Miller, S.I. Polymyxin resistance and lipid A structure of Pseudomonas aeruginosa isolated from colistin-treated and colistin-naîve cystic fibrosis patients. Pediatr Pulmonol Suppl 20 (2000) 272.
Moskowitz, S.M., Chmiel, J.F., Sternen, D.L., Cheng, E., Gibson, R.L., Marshall, S.G., Cutting, G.R. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med 10 (2008) 851–868.
Moskowitz, S.M., Ernst, R.K., Miller, S.I. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol 186 (2004) 575–579.
Palsson-McDermott, E.M., O’Neill, L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113 (2004) 153–162.
Pamp, S.J., Gjermansen, M., Johansen, H.K., Talker-Nielsen, T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol 68 (2008) 223–240.
Pujana, I., Gallego, L., Martin, G., Lopez, F., Candela, J., Cisterna, R. Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis. J Clin Microbiol 37 (1999) 2071–2073.
Rajan, S., Saiman, L. Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 17 (2002) 47–56.
Reid, G., Charbonneau-Smith, R., Lam, D., Kang, Y.S., Lacerte, M., Hayes, K.C. Bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia 30 (1992) 711–717.
Romling, U., Fiedler, B., Bosshammer, J., Grothues, D., Greipel, J., von der Hardt, H., Tummler, B. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J Infect Dis 170 (1994) 1616–1621.
Singh, P.K., Schaefer, A.L., Parsek, M.R., Moninger, T.O., Welsh, M.J., Greenberg, E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407 (2000) 762–764.
Thomas, S.R., Ray, A., Hodson, M.E., Pitt, T.L. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55 (2000) 795–797.
Trent, M.S., Pabich, W., Raetz, C.R., Miller, S.I. A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J Biol Chem 276 (2001) 9083–9092.
Tummler, B., Bosshammer, J., Breitenstein, S., Brockhausen, I., Gudowius, P., Herrmann, C., Herrmann, S., Heuer, T., Kubesch, P., Menus, F., Romling, U., Schmidt, K.D., Spangenberg, C., Walter, S. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst Mitt (1997) 249–255.
van Heeckeren, A., Walenga, R., Konstan, M.W., Bonfield, T., Davis, P.B., Ferkol, T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 100 (1997) 2810–2815.
Acknowledgments
The review was supported by grants from the U.S. National Institutes of Health (NIH) to SMM (R01AI067653) and RKE (R01AI047938)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Moskowitz, S.M., Ernst, R.K. (2010). The Role of Pseudomonas Lipopolysaccharide in Cystic Fibrosis Airway Infection. In: Wang, X., Quinn, P. (eds) Endotoxins: Structure, Function and Recognition. Subcellular Biochemistry, vol 53. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9078-2_11
Download citation
DOI: https://doi.org/10.1007/978-90-481-9078-2_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9077-5
Online ISBN: 978-90-481-9078-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)